Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
7680616360021
CH-61636
B06AC01
06.01.1.
Active substances:
1 / 3
google
Details
- Product number
- 6163601
- CPT
- -
- Packaging group
- -
- Unit
- 2 Fl. à 500 IE/UI Pulver + 2 Fl. à 5 ml Lösungsmittel und Verabreichungsset
- Composition
- Praeparatio cryodesiccata: C1-esterasi inhibitor humanus 500 U.I., natrii citras dihydricus, natrii chloridum, valinum, alaninum, threoninum, saccharum, pro vitro corresp. natrium 11.5 mg. Solvens: aqua ad iniectabile, pro vitro.
Articles (1)
Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
C1-esterasi inhibitor humanus
|
500.0 UI | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
valinum
|
- | Substance | HNIDK |
|
alaninum
|
- | Substance | HNIDK |
|
threoninum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
natrium
|
11.5 MG | Substance | HBESI |
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61636
- Drug name
- Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMI
- ATC Code
- B06AC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/05/2013
- Authorization expiration date
- 31/08/2026
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CINRYZE subst sèche 500 UI c solv 2 pce
- Description (DE)
- CINRYZE Trockensub 500 IE c Solv 2 Stk
- Market launch
- 23/05/2013
- Market withdrawal
- 24/06/2026
- Narcotic (BTM)
- No